Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-119090

CFO, EVP & Treasurer sold 59,250 shares at an average $55.67 ($3,298,475)

  • CFO, EVP & Treasurer acquired 59,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Option exercise 10b5-1 +21,250 $20.23 $429,888 122,610 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Option exercise 10b5-1 +38,000 $13.03 $495,140 160,610 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Sale 10b5-1 −14,220 $54.76 $778,724 146,390 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Sale 10b5-1 −30,162 $55.67 $1,679,203 116,228 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Sale 10b5-1 −14,868 $56.53 $840,548 101,360 D
Derivatives
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Option exercise · Employee Stock Option (right to buy) 10b5-1 −21,250 15,225 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-11-14 Option exercise · Employee Stock Option (right to buy) 10b5-1 −38,000 31,100 D
Open-market sales · 59,250 sh · avg $55.67 · $3,298,475
Loading xslF345X05/tm2330835-3_4seq1.xml…